Donald B. Kohn, M.D.

Quick facts

Phase 2 pipeline

• ADA gene transfer · Immunology
  ADA gene transfer involves the introduction of a healthy copy of the ADA gene into a patient's hematopoietic stem cells to treat ADA-SCID.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Donald B. Kohn, M.D. portfolio CI brief
• Donald B. Kohn, M.D. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies